To provide a water-absorbing resin composition having both a high centrifuge retention capacity (CRC) and a sufficient urine resistance and a method for producing such a water-absorbing resin composition, an aspect of the present invention is a water-absorbing resin composition having the following properties: (1) A centrifuge retention capacity (CRC) being not less than 35 g/g; (2) A post-degradation-test one-hour eluted soluble component being not more than 19% by mass; (3) An absorbency against pressure 0.7 psi (AAP0.7) being not less than 10 g/g; and (4) A content of a water-absorbing resin in dust being not more than 300 ppm with respect to a total mass of the water-absorbing resin composition.

Disclosed is an absorbent article comprising; (a) a topsheet having a skin facing side and a core facing side, the topsheet being liquid permeable and having the core facing side coated with at least about 0.01 mg/m.sup.2, preferably from about 0.05 mg/m.sup.2 to about 0.2 mg/m.sup.2, of calcium carbonate; (b) a backsheet which is liquid impermeable; and (c) an absorbent core comprising an absorbent material, the absorbent core disposed between the topsheet and the backsheet.

Disclosed is an absorbent article comprising; (a) a topsheet having a skin facing side and a core facing side, the topsheet being liquid permeable and having the core facing side coated with at least about 0.01 mg/m.sup.2, preferably from about 0.05 mg/m.sup.2 to about 0.2 mg/m.sup.2, of calcium carbonate; (b) a backsheet which is liquid impermeable; and (c) an absorbent core comprising an absorbent material, the absorbent core disposed between the topsheet and the backsheet.

A medical device and an activating method thereof, wherein the medical device is suitable for preventing and/or treating an infection of a skin lesion and includes: (i) a substrate consisting essentially of cellulose, (ii) at least one cationic copolymer obtained by reaction of at least one polyamine, at least one polyamidoamine or a mixture thereof with at least one polyisocyanate, wherein the copolymer is anchored to the substrate, and optionally (iii) at least one dermatologically acceptable amphoteric surfactant.

A water permeability-imparting agent containing an alkylene oxide adduct (A) of a polyvalent active hydrogen compound represented by Formula (1):
R[O(A.sup.1O).sub.m(CH.sub.2CH.sub.2O).sub.nH].sub.1(1)
wherein R represents a residue, after removal of all active hydrogen, of the polyvalent active hydrogen compound; A.sup.1O represents a C2 to C4 alkyleneoxy group; m represents an average addition mole number of A.sup.1O and is a number of 4 to 50; n represents an average addition mole number of CH.sub.2CH.sub.2O; and 1 represents a valence and is an integer of 3 to 6, and an average addition mole number ratio between A.sup.1O and CH.sub.2CH.sub.2O in Formula (1), n/m, is 0 to 0.5.

A water permeability-imparting agent containing an alkylene oxide adduct (A) of a polyvalent active hydrogen compound represented by Formula (1):
R[O(A.sup.1O).sub.m(CH.sub.2CH.sub.2O).sub.nH].sub.1(1)
wherein R represents a residue, after removal of all active hydrogen, of the polyvalent active hydrogen compound; A.sup.1O represents a C2 to C4 alkyleneoxy group; m represents an average addition mole number of A.sup.1O and is a number of 4 to 50; n represents an average addition mole number of CH.sub.2CH.sub.2O; and 1 represents a valence and is an integer of 3 to 6, and an average addition mole number ratio between A.sup.1O and CH.sub.2CH.sub.2O in Formula (1), n/m, is 0 to 0.5.

Provided is a water-absorbing agent that causes no or little fluctuation of feed rate when fed with use of a feeder. A water-absorbing agent containing a water-absorbing resin as a main component, the water-absorbing agent satisfying the following (a) and (b): (a) K-index is 70 or more; and (b) Moisture absorption blocking ratio, after 30 minutes of standing at a temperature of 25 C. and a relative humidity of 80% RH, is 70 weight % or less, the K-index being defined by the following equation: K-index=100(438+3.6angle of repose+3.5angle of difference+7.9compressibility rate+290bulk density (EDANA method)).

The present technology generally provides biophotonic silicone membranes and methods useful in the management of scars. In particular, the biophotonic silicone membranes of the present technology are useful in preventing and/or treating post-surgical scar formation.

The present technology generally provides biophotonic silicone membranes and methods useful in the management of scars. In particular, the biophotonic silicone membranes of the present technology are useful in preventing and/or treating post-surgical scar formation.

Provided herein are fabric materials and debridement devices comprising gel-forming hydrofibres for disrupting a biofilm, loosening, or sequestering unwanted materials from wounds, and uses thereof. In particular, debridement and detection devices for selective and atraumatic removal of unwanted tissues and for detection of a wound infection are provided.